Percutaneous radiofrequency ablation of lung cancer

The Lancet Oncology

Volumn 9, Issue 7, 2008, Pages 604-605

  Hiraki, Takao ^a   Gobara, Hideo ^a   Mimura, Hidefumi ^a   Sano, Yoshifumi ^a   Kanazawa, Susumu ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ESOPHAGITIS; HUMAN; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; NON INVASIVE PROCEDURE; OVERALL SURVIVAL; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; SALVAGE THERAPY; STEREOTACTIC TREATMENT; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; TREATMENT OUTCOME;

EID: 45849084961     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70159-1     Document Type: Letter

References (10)

1. Steinke K., Sewell P., Dupuy D., et al. Pulmonary radiofrequency ablation-an international study survey. Anticancer Res 24 (2004) 339-344
2. Pennathur A., Luketich J., Abbas G., et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 134 (2007) 857-864
3. Hiraki T., Gobara H., Iishi T., et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 134 (2007) 1306-1312
4. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9 (2008) 621-628
5. Ambrogi M., Lucchi M., Dini P., et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 30 (2006) 177-183
6. Hiraki T., Sakurai J., Tsuda T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 107 (2006) 2873-2880
7. Simon C., Dupuy D., DiPetrillo T., et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243 (2007) 268-275
8. de Baere T., Palussiere J., Auperin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240 (2006) 587-596
9. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2 (2007) 94-100
10. Nagata Y., Matsuo Y., Takayama K., et al. Current status of stereotactic body radiotherapy for lung cancer. Int J Clin Oncol 12 (2007) 3-7